Lake Street Reiterates Buy on NeuroPace, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen has reiterated a Buy rating on NeuroPace (NASDAQ:NPCE) and maintained a $12 price target for the company's stock.
December 27, 2023 | 2:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Lake Street analyst Frank Takkinen reaffirmed a Buy rating on NeuroPace and kept a $12 price target, indicating a positive outlook for the stock.
The reiteration of a Buy rating and maintenance of a $12 price target by a reputable analyst like Frank Takkinen could lead to increased investor confidence in NPCE, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100